GILD - Where is the bottom?Where is the bottom? I absolutely DO NOT have the answer. Volume corresponding to GILD price is interesting. I don't often look at 1M, but it does give an interesting perspective. Short interest is .98%. I'ts been dropping since 2013. 1W: 1M CELG Comparison: by JLJ0025006
GILD hitting Major Support LineGilead Sciences is a deep value play, along the likes of a Joel Greenblatt "Magic Formula" stock. Around September I expressed a bullish interest in GILD given its fundamentals and its valuation. During that time, GILD traded at $73. Since I expressed a long interest, the stock has done nothing but decline. Looking back on my initial bullish opinion, I didn't take into consideration the charts, let alone even think about TA. The fundamental research was over, and due to the fundamentals I didn't really think to take a look at the charts. After all, it was my inner Buffett saying, "Hey, this is a great business, don't even worry about the price, since the company is so great, it doesn't matter. Heck, if it goes lower, buy more!" Well, after reflecting on this consensus I realized how foolish it was of me. If I would've taken the time to look at the charts, I would have realized that at $73, it didn't have much support on that level, with the most recent support level being at $66.51. So, instead of waiting for that support price to hit, I thought it would be a good idea to buy at $73. Not only did that bullish decision reflect in a loss of capital, but it resulted in dead money, money that could've been used in other capital allocations. Nevertheless, I like GILDs fundamentals so much I had to take a second look as the share price kept falling. Now, at $66.51, GILD is right at the support level from mid 2014. GILD is still in a bearish channel, but since the company is so solid on its balance sheet and has loads of cash, if the bearish channel is broken upward, I will look to get in around the $71 level. Will keep watching. All the best, RCLongby BrandonBeylo4
GILD fitting in nicely.downtrend on the weekly (orange). blue-dashed line is the monthly support.Shortby whackitall5
Gilead head and shoulders pattern. Levels of support if the head and shoulders pattern continues is $68, $53, and $38. by DathanPyle5
GILD short opportunityGILD recently bounced to its .618 retracement on what is likely a short squeeze via trading algorithms at the open. Enter this puppy short for the next downside wave. Target should be $65.Shortby mologna5
Gilead Sciences Inc. A verry good investment.FUNDAMENTAL AND TECHNICAL. An effective cure for hepatitis have sent one of the world's most well-run pharmaceutical company Gilead Sciences on sale The medication works, patients become well, and everyone should be happy. But the problem is that the medication works to well and patients doesn't need the medication further after the treatment. and this can harm the revenue for the company. THE TECHNICAL The E-P-S (earnings pr share) is actually pretty high at 9.94. The P-E(Price Ernings) Ratio is at 6.94 so investors are willing to pay 6,94 Dollar pr dollar ernings. where the E-P-S is at 9,94 the dividend yield is at 2,97% therefore Gilead sciences dividend payout ratio is = 2,97/(1/6,94)= 20,61 % So the dividend payout ratio is really high and we could se an increase in the stock at 20,61% that is an increase of 14,28 Dollars pr share. i will be updating this in the comment with more fundamentals. Longby Fx-AlphaStrats6
Gilead could break downward channel and pop up In downward channel - look for it to break on the upside. Low 7 PE and pays dividend. verifiedinvesting.comLongby siciliansliceUpdated 114
2017 is GILD's year ?70s is the target for the coming couple of weeks any close above 77 confirms the positivity and close below 66 is a stop loss Longby chancehunter2
Buy low sell highGILD is right at a very nice buy low sell high area on the weekly chart. We hit this level and bounced back in 2014 Longby carley6213
Gilead Sciences - hit 2014-04-10 support level. I don't have a position in this stock, but I am waiting patiently to enter with a medium-long term strategy. For the following reasons: 1. Appr. 50% reduction in price from all time high in USD$123 (june 2015) to USD$65 (feb 2017). 2. USD$65 is the previous support level from 2014-04-10. 3. The stock has gapped twice already 1# 2016-07-25 and 2# 2017-02-08. 4. Risk:Reward is 1:3.62 My strategy would be to enter USD$ 66-67, with a Stop-loss in $58 and first time target in $83 and wait for the possible retracement, and then pick up some more shares and next target in $97. I am no professional investor or investment advisor, but is doing this solely for the sport. Please comment if you disagree/agree. Longby Greendiamonds4
Head&Shoulders Formed On the WeeklyThis is an ugly chart for those who are bullish on GILD. I do not hold short biotech positions overnight so I will not be entering this trade. This chart is just to show that the recent crash in biotech still has a way to go.Shortby the_get_manUpdated 3